Psychedelics & Cannabis

Latest News

LIPSKIY/SHUTTERSTOCK.COM; WITHTHESEHANDS/SHUTTERSTOCK.COM

June 26th 2018

Revisiting the Hallucinogenic Potential of Ketamine

By David S. Mathai, MD, Sanjay J. Mathew, MD, Eric A. Storch, PhD

An exploration of findings from contemporary research that hint at the unexplored hallucinogenic potential of ketamine and considerations for future investigation.

April 20th 2017

Innovative Strategies for Addressing Substance Use Disorders: The Classic Hallucinogens

By Michael P. Bogenschutz, MD

January 12th 2012

The Cannabis-Psychosis Link

By Marie-josee Lynch, MD, Rachel A. Rabin, MSc, Tony P. George, MD, FRCPC

CME Content

Video

Clear Skin, Clear Mind: Integrating Mental Health into Psoriasis Care

John Koo, MD; T.J. Chao, MPAS, PA-C

Video

Expert Illustrations & Commentary: Visualizing the Role of Novel Muscarinic Agents in the Management of Schizophrenia

Ilan Melnick, MD; Linda Collado, MD, DABPN, FAPA; Maria Collado, MD, FAPA

Video

Expert Illustrations & Commentary: Visualizing Novel Therapeutic Targets for Patients with Major Depressive Disorder

Juan D. Oms, MD, FAPA; Linda Collado, MD, DABPN, FAPA; Ginger Shupe, MD

Video

(CPE Track) SoCal Psych 2025: Overcoming Barriers to Long-Acting Injectable Agents in Schizophrenia

Gus Alva, MD, DFAPA; Ilan Melnick, MD

Video

Live Expert Illustrations & Commentary™: Visualizing Novel Therapeutic Targets for Patients with Major Depressive Disorder

Jason Kellogg, MD; Gus Alva, MD, DFAPA; Melanie Barrett, MD; Yvette Elpidio, MSN, FNP-C

Video

Cases and Conversations™: Optimizing Administration of Treatment for Patients with Schizophrenia

Gus Alva, MD, DFAPA; Erin Crown, MHS, PA-C

Psychedelics & Cannabis

Latest News

CME Content

Clear Skin, Clear Mind: Integrating Mental Health into Psoriasis Care

Expert Illustrations & Commentary: Visualizing the Role of Novel Muscarinic Agents in the Management of Schizophrenia

Expert Illustrations & Commentary: Visualizing Novel Therapeutic Targets for Patients with Major Depressive Disorder

(CPE Track) SoCal Psych 2025: Overcoming Barriers to Long-Acting Injectable Agents in Schizophrenia

Live Expert Illustrations & Commentary™: Visualizing Novel Therapeutic Targets for Patients with Major Depressive Disorder

Cases and Conversations™: Optimizing Administration of Treatment for Patients with Schizophrenia

Trending on Psychiatric Times

When Antidepressants Stop Working: Understanding Tachyphylaxis in Clinical Practice

What Do Patient-Level Studies Tell Us About Antidepressants and Suicide Risk?

The Psych Consult: TSH Testing in New-Onset Depression. An Endocrinologist’s Guidance for Psychiatrists

ADHD Medications for Managing Menopausal Brain Fog: Improvements in Subjective Executive Function

Sleep Disruption and Alzheimer Disease: A Bidirectional, Treatable Relationship